Prognostic value and immunological role of CSNK1D in human cancers.
CSNK1D
HCC
cancer
immune infiltration
prognosis
Journal
Aging
ISSN: 1945-4589
Titre abrégé: Aging (Albany NY)
Pays: United States
ID NLM: 101508617
Informations de publication
Date de publication:
08 09 2023
08 09 2023
Historique:
received:
21
05
2023
accepted:
24
07
2023
medline:
22
9
2023
pubmed:
9
9
2023
entrez:
9
9
2023
Statut:
ppublish
Résumé
CSNK1D, also known as CK1δ, is a crucial gene involved in various biological processes such as cell cycle, transcriptional regulation, apoptosis, cell polarity, and cell motility. It is associated with different cancers and neurodegenerative diseases. This study aimed to investigate the role of CSNK1D in multiple human cancers, particularly hepatocellular carcinoma (HCC), through
Identifiants
pubmed: 37688771
pii: 205009
doi: 10.18632/aging.205009
pmc: PMC10522368
doi:
Substances chimiques
Casein Kinase Idelta
EC 2.7.11.1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
8948-8975Références
Exp Cell Res. 2001 Feb 1;263(1):43-54
pubmed: 11161704
Cell. 2019 Jan 10;176(1-2):11-42
pubmed: 30633901
Trends Cell Biol. 2019 Mar;29(3):212-226
pubmed: 30594349
Biol Proced Online. 2022 Dec 2;24(1):21
pubmed: 36460966
Mol Cell Endocrinol. 2015 May 5;406:87-101
pubmed: 25724478
J Cell Biol. 2011 Mar 21;192(6):993-1004
pubmed: 21422228
Mol Cancer. 2020 Jan 22;19(1):12
pubmed: 31969156
Nat Chem Biol. 2010 Nov;6(11):829-36
pubmed: 20890287
Biomed Pharmacother. 2020 Jan;121:109595
pubmed: 31710896
Tumour Biol. 2016 Jul;37(7):8731-9
pubmed: 26738869
Cancer Res. 2004 Nov 1;64(21):8036-44
pubmed: 15520213
Brief Bioinform. 2021 May 20;22(3):
pubmed: 32823273
Exp Mol Med. 2018 Dec 13;50(12):1-11
pubmed: 30546008
J Biol Chem. 1993 Mar 25;268(9):6394-401
pubmed: 8454611
Genomics. 1996 Feb 15;32(1):140-3
pubmed: 8786104
Nat Rev Immunol. 2020 Jan;20(1):25-39
pubmed: 31570880
PLoS One. 2009;4(1):e4174
pubmed: 19137063
J Immunol. 2018 Jan 15;200(2):432-442
pubmed: 29311385
Mol Cell. 2011 Oct 21;44(2):317-24
pubmed: 22017877
Front Immunol. 2022 Aug 04;13:951137
pubmed: 35990657
Cancer Cell. 2021 Feb 8;39(2):154-173
pubmed: 33125859
Neuropsychopharmacology. 2012 Aug;37(9):2121-31
pubmed: 22549116
Pathol Res Pract. 2022 Dec;240:154187
pubmed: 36327821
Neurobiol Aging. 2000 Jul-Aug;21(4):503-10
pubmed: 10924763
Cell Signal. 2005 Jun;17(6):675-89
pubmed: 15722192
Dev Cell. 2019 May 6;49(3):361-374
pubmed: 31063755
Aging (Albany NY). 2020 Apr 13;12(7):5764-5780
pubmed: 32282334
Eur J Cell Biol. 2000 Apr;79(4):240-51
pubmed: 10826492
Front Endocrinol (Lausanne). 2022 Nov 28;13:1045167
pubmed: 36518255
Cancer Lett. 2020 Feb 1;470:126-133
pubmed: 31730903
Int J Cancer. 2015 Jun 15;136(12):2799-810
pubmed: 25404202
Signal Transduct Target Ther. 2021 Mar 29;6(1):128
pubmed: 33776057
Eur J Cancer Prev. 2020 Sep;29(5):367-381
pubmed: 32740162
Sci Rep. 2016 Jul 21;6:29983
pubmed: 27439882
Mol Biol Cell. 2014 May;25(10):1629-40
pubmed: 24648492
BMC Cancer. 2016 Aug 03;16:594
pubmed: 27488834
Dev Cell. 2010 Apr 20;18(4):579-91
pubmed: 20412773
Mol Cancer. 2014 Oct 11;13:231
pubmed: 25306547
Sci Transl Med. 2015 Dec 16;7(318):318ra202
pubmed: 26676609
Oncogene. 2011 Jun 2;30(22):2558-69
pubmed: 21258417
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Cancer Lett. 2017 Feb 28;387:61-68
pubmed: 26845449